Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy

Disturbances in the ubiquitin proteasome system, and especially changes of the E3 ligases, are subjects of interest when searching for causes and therapies for cardiomyopathies. The aim of this study was to clarify whether the myostatin/AKT/forkhead box O (FOXO) pathway, which regulates the expressi...

Full description

Bibliographic Details
Main Authors: Lea Hildebrandt, Maja-Theresa Dieterlen, Kristin Klaeske, Josephina Haunschild, Diyar Saeed, Sandra Eifert, Michael A. Borger, Khalil Jawad
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/12/9/1418
_version_ 1827659451659714560
author Lea Hildebrandt
Maja-Theresa Dieterlen
Kristin Klaeske
Josephina Haunschild
Diyar Saeed
Sandra Eifert
Michael A. Borger
Khalil Jawad
author_facet Lea Hildebrandt
Maja-Theresa Dieterlen
Kristin Klaeske
Josephina Haunschild
Diyar Saeed
Sandra Eifert
Michael A. Borger
Khalil Jawad
author_sort Lea Hildebrandt
collection DOAJ
description Disturbances in the ubiquitin proteasome system, and especially changes of the E3 ligases, are subjects of interest when searching for causes and therapies for cardiomyopathies. The aim of this study was to clarify whether the myostatin/AKT/forkhead box O (FOXO) pathway, which regulates the expression of the E3 ligases muscle atrophy F-box gene (MAFbx) and muscle ring-finger protein-1 (MuRF1), is changed in dilated cardiomyopathy of ischemic origin (IDCM) and dilated cardiomyopathy of non-ischemic origin (NIDCM). The mRNA and protein expression of myostatin, AKT, FOXO1, FOXO3, MAFbx and MuRF1 were quantified by real-time polymerase chain reaction and ELISA, respectively, in myocardial tissue from 26 IDCM and 23 NIDCM patients. Septal tissue from 17 patients undergoing Morrow resection served as a control. MAFbx and FOXO1 mRNA and protein expression (all <i>p</i> < 0.05), AKT mRNA (<i>p</i> < 0.01) and myostatin protein expression (<i>p</i> = 0.02) were decreased in NIDCM patients compared to the control group. Apart from decreases of AKT and MAFbx mRNA expression (both <i>p</i> < 0.01), no significant differences were detected in IDCM patients compared to the control group. Our results demonstrate that the myostatin/AKT/FOXO pathway is altered in NIDCM but not in IDCM patients. FOXO1 seems to be an important drug target for regulating the expression of MAFbx in NIDCM patients.
first_indexed 2024-03-09T23:22:38Z
format Article
id doaj.art-98109ae13b414571afe09b439e5e2259
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T23:22:38Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-98109ae13b414571afe09b439e5e22592023-11-23T17:23:47ZengMDPI AGLife2075-17292022-09-01129141810.3390/life12091418Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated CardiomyopathyLea Hildebrandt0Maja-Theresa Dieterlen1Kristin Klaeske2Josephina Haunschild3Diyar Saeed4Sandra Eifert5Michael A. Borger6Khalil Jawad7Department of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDepartment of Cardiac Surgery, Heart Center, HELIOS Clinic, University Hospital Leipzig, 04289 Leipzig, GermanyDisturbances in the ubiquitin proteasome system, and especially changes of the E3 ligases, are subjects of interest when searching for causes and therapies for cardiomyopathies. The aim of this study was to clarify whether the myostatin/AKT/forkhead box O (FOXO) pathway, which regulates the expression of the E3 ligases muscle atrophy F-box gene (MAFbx) and muscle ring-finger protein-1 (MuRF1), is changed in dilated cardiomyopathy of ischemic origin (IDCM) and dilated cardiomyopathy of non-ischemic origin (NIDCM). The mRNA and protein expression of myostatin, AKT, FOXO1, FOXO3, MAFbx and MuRF1 were quantified by real-time polymerase chain reaction and ELISA, respectively, in myocardial tissue from 26 IDCM and 23 NIDCM patients. Septal tissue from 17 patients undergoing Morrow resection served as a control. MAFbx and FOXO1 mRNA and protein expression (all <i>p</i> < 0.05), AKT mRNA (<i>p</i> < 0.01) and myostatin protein expression (<i>p</i> = 0.02) were decreased in NIDCM patients compared to the control group. Apart from decreases of AKT and MAFbx mRNA expression (both <i>p</i> < 0.01), no significant differences were detected in IDCM patients compared to the control group. Our results demonstrate that the myostatin/AKT/FOXO pathway is altered in NIDCM but not in IDCM patients. FOXO1 seems to be an important drug target for regulating the expression of MAFbx in NIDCM patients.https://www.mdpi.com/2075-1729/12/9/1418heart failurecardiomyopathyprotein breakdownE3 ligasesFOXOMAFbx
spellingShingle Lea Hildebrandt
Maja-Theresa Dieterlen
Kristin Klaeske
Josephina Haunschild
Diyar Saeed
Sandra Eifert
Michael A. Borger
Khalil Jawad
Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
Life
heart failure
cardiomyopathy
protein breakdown
E3 ligases
FOXO
MAFbx
title Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
title_full Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
title_fullStr Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
title_full_unstemmed Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
title_short Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
title_sort myostatin akt foxo signaling is altered in human non ischemic dilated cardiomyopathy
topic heart failure
cardiomyopathy
protein breakdown
E3 ligases
FOXO
MAFbx
url https://www.mdpi.com/2075-1729/12/9/1418
work_keys_str_mv AT leahildebrandt myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT majatheresadieterlen myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT kristinklaeske myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT josephinahaunschild myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT diyarsaeed myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT sandraeifert myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT michaelaborger myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy
AT khaliljawad myostatinaktfoxosignalingisalteredinhumannonischemicdilatedcardiomyopathy